Effect of Wnt-1 inducible signaling pathway protein-2 (WISP-2/CCN5), a downstream protein of Wnt signaling, on adipocyte differentiation

Biochemical and Biophysical Research Communications

Volumn 379, Issue 4, 2009, Pages 969-974

  Inadera, Hidekuni ^a   Shimomura, Akiko ^a   Tachibana, Shinjiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Adipocyte; TNF ; WISP 2; Wnt

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN GAMMA; LITHIUM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WNT 1 INDUCIBLE SIGNALING PATHWAY PROTEIN 2; WNT1 PROTEIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CULTURE MEDIUM; DOWN REGULATION; IN VITRO STUDY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

3T3 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; GLYCOGEN SYNTHASE KINASE 3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LITHIUM; MICE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; WNT PROTEINS;

EID: 58949092472     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.185     Document Type: Article

References (34)

1. Cornelius P., MacDougald O.A., and Lane M.D. Regulation of adipocyte development. Annu. Rev. Nutr. 14 (1994) 99-129
2. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocrinol. Rev. 27 (2006) 762-778
3. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
4. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., and MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
5. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., Harrison S.D., and MacDougald O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277 (2002) 30998-31004
6. Longo K.A., Kennell J.A., Ochocinska M.J., Ross S.E., Wright W.S., and MacDougald O.A. Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J. Biol. Chem. 277 (2002) 38239-38244
7. Pennica D., Swanson T.A., Welsh J.W., Roy M.A., Lawrence D.A., Lee J., Brush J., Taneyhill L.A., Deuel B., Lew M., Watanabe C., Cohen R.L., Melhem M.F., Finley G.G., Quirke P., Goddard A.D., Hillan K.J., Gurney A.L., Botstein D., and Levine A.J. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95 (1998) 14717-14722
8. Zhang R., Averboukh L., Zhu W., Zhang H., Jo H., Dempsey P.J., Coffey R.J., Pardee A.B., and Liang P. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol. Cell Biol. 18 (1998) 6131-6141
9. Lake A.C., Bialik A., Walsh K., and Castellot Jr. J.J. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility. Am. J. Pathol. 162 (2003) 219-231
10. Kohanski R.A., Frost S.C., and Lane M.D. Insulin-dependent phosphorylation of the insulin receptor-protein kinase and activation of glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 261 (1986) 12272-12281
11. Inadera H., Hashimoto S., Dong H.Y., Suzuki T., Nagai S., Yamashita T., Toyoda N., and Matsushima K. WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 275 (2000) 108-114
12. Kitamura T., Koshino Y., Shibata F., Oki T., Nakajima H., Nosaka T., and Kumagai H. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31 (2003) 1007-1014
13. Inadera H., Dong H.Y., and Matsushima K. WISP-2 is a secreted protein and can be a marker of estrogen-exposure in MCF-7 cells. Biochem. Biophys. Res. Commun. 294 (2002) 602-608
14. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
15. Patel Y.M., and Lane M.D. Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J. Biol. Chem. 275 (2000) 17653-17660
16. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells. Curr. Biol. 6 (1996) 1664-1668
17. Rosenbaum S.E., and Greenberg A.S. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. Mol. Endocrinol. 12 (1998) 1150-1160
18. Inadera H. Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway. Biochem. Biophys. Res. Commun. 309 (2003) 272-278
19. Brigstock D.R. The CCN family: a new stimulus package. J. Endocrinol.178 (2003) 169-175
20. Perbal B. CCN proteins: multifunctional signaling regulators. Lancet 363 (2004) 62-64
21. Kumar S., Hand A.T., Connor J.R., Dodds R.A., Ryan P.J., Trill J.J., Fisher S.M., Nuttall M.E., Lipshutz D.B., Zou C., Hwang S.M., Votta B.J., James I.E., Rieman D.J., Gowen M., and Lee J.C. Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblasts functions. J. Biol. Chem. 274 (1999) 17123-17131
22. Tang Q.Q., Otto T.C., and Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 844-849
23. Tang Q.Q., and Lane M.D. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 13 (1999) 2231-2241
24. Wu Z., Xie Y., Bucher N.L., and Farmer S.R. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev. 9 (1995) 2350-2363
25. Belmonte N., Phillips B.W., Massiera F., Villageois P., Wdziekonski B., Saint-Marc P., Nichols J., Aubert J., Saeki K., You A., Narumiya S., Ailhaud G., and Dani C. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and -delta in preadipocytes. Mol. Endocrinol. 15 (2001) 2037-2049
26. Zhang B., Berger J., Hu E., Szalkowski D., White-Carrington S., Spiegelman B.M., and Moller D.E. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol. Endocrinol. 10 (1996) 1457-1466
27. Ruan H., Hacohen N., Golub T.R., Van Parijs L., and Lodish H.F. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappa B activation by TNF-alpha is obligatory. Diabetes 51 (2002) 1319-1336
28. Suzawa M., Takada I., Yanagisawa J., Ohtake F., Ogawa S., Yamauchi T., Kadowaki T., Takeuchi Y., Shibuya H., Gotoh Y., Matsumoto K., and Kato S. Cytokines suppress adipogenesis and peroxisome proliferator-activated receptor-gamma function through the TAK1/TAB1/NIK cascade. Nat. Cell Biol. 5 (2003) 224-230
29. Tan J.T., McLennan S.V., Song W.W., Lo L.W., Bonner J.G., Williams P.F., and Twigg S.M. Connective tissue growth factor inhibits adipocyte differentiation. Am. J. Physiol. Cell Physiol. 295 (2008) C740-C751
30. Mo F.E., Muntean A.G., Chen C.C., Stolz D.B., Watkins S.C., and Lau L.F. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol. Cell Biol. 22 (2002) 8709-8720
31. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., Daluiski A., and Lyons K.M. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130 (2003) 2779-2791
32. Heath E., Tahri D., Andermarcher E., Schofield P., Fleming S., and Boulter C.A. Abnormal skeletal cardiac development cardiomyopathy muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev. Biol. 8 (2008) 18
33. Hurvitz J.R., Suwairi W.M., Van Hul W., El-Shanti H., Superti-Furga A., Roudier J., Holderbaum D., Pauli R.M., Herd J.K., Van Hul E.V., Rezai-Delui H., Legius E., Le Merrer M., Al-Alami J., Bahabri S.A., and Warman M.L. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 23 (1999) 94-98
34. Gray M.R., Malmquist J.A., Sullivan M., Blea M., and Castellot Jr. J.J. CCN5 expression in mammals. II. Adult rodent tissues. J. Cell Commun. Signalling 1 (2007) 145-158